Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of NSF on Acute Stress
DRKS00012868Phase 3Completed
- Sponsor
- NMC Healthcare
- Start
- Aug 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of Lactium + ETAS in acute stress reaction (ASR) (2 arms), sponsored by NMC Healthcare. Started Aug 2017; status: completed.
02
Drugs
Lactium + ETAS
03
Conditions
acute stress reaction (ASR)
Beyond the preview
Go deeper on DRKS00012868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012868.